CFB inhibitors identified by Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine July 27, 2022 No Comments
Calyxo garners $32.7M for kidney stone treatment July 8, 2022 By Annette Boyle No Comments Calyxo Inc. cleaned up with a $32.7 million series C financing round to support further development of the Cvac system for kidney stones. Questa Capital and CRG led the round, which brought the company’s total funds raised to $47.2 million.Read More
AstraZeneca, Mitsubishi Tanabe Pharma present new relaxin receptor 1 agonists July 7, 2022 No Comments
Walden Biosciences enters research collaboration with University of Michigan on suPAR genetics July 6, 2022 No Comments
New K(Ca) 1.1 channel activators identified at Gwangju Institute of Science and Technology May 5, 2022 No Comments
RSS
